AstraZeneca, Amgen Drug Moves Closer to Competing With Dupixent in a New IndicationNews DeskAugust 27, 20260 There’s one FDA-approved biologic drug for the immunological disorder eosinophilic esophagitis, or EoE. An AstraZeneca and Amgen antibody is bolstering…